Triumeq and Hypertriglyceridaemia - a phase IV clinical study of FDA data

Summary:

Hypertriglyceridaemia is reported as a side effect among people who take Triumeq (abacavir sulfate; dolutegravir sodium; lamivudine), especially for people who are male, 40-49 old, have been taking the drug for 5 - 10 years also take Xyzal, and have Asthma.

The phase IV clinical study analyzes which people have Hypertriglyceridaemia when taking Triumeq. It is created by eHealthMe based on reports of 6,839 people who have side effects when taking Triumeq from the FDA, and is updated regularly.

What is Triumeq?

Triumeq has active ingredients of abacavir sulfate; dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 6,900 Triumeq users. Check the latest studies of Triumeq.

What is Hypertriglyceridaemia?

Hypertriglyceridaemia (excess of triglycerides in the blood) is found to be associated with 761 drugs and 761 conditions by eHealthMe. Check the latest studies of Hypertriglyceridaemia.

On Jul, 09, 2026

6,839 people reported to have side effects when taking Triumeq.
Among them, 16 people (0.23%) have Hypertriglyceridaemia.

Could Triumeq cause Hypertriglyceridaemia?

Among these 16 people:

How long have people been on Triumeq when they have Hypertriglyceridaemia? *

What is the gender of people who have Hypertriglyceridaemia when taking Triumeq? *

female: 0.0 %
male: 100 %

What is the age of people who have Hypertriglyceridaemia when taking Triumeq? *

What are other drugs people take besides Triumeq? *

What are other side effects people have besides Hypertriglyceridaemia? *

High Blood Pressure: 6 people, 37.50%
Type 2 Diabetes: 6 people, 37.50%
Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum): 3 people, 18.75%
Hepatic Function Abnormal: 3 people, 18.75%
Hyperglycemia (high blood sugar): 2 people, 12.50%
Blood Hiv Rna Increased: 2 people, 12.50%
Dermal Cyst: 2 people, 12.50%
Weight Loss: 2 people, 12.50%
Lymphocyte Count Decreased: 2 people, 12.50%
Joint Stiffness: 1 person, 6.25%

What are the existing conditions these people have? *

Asthma: 7 people, 43.75%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 37.50%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 37.50%
Diabetes: 4 people, 25.00%
Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum): 3 people, 18.75%
Sleep Disorder: 2 people, 12.50%
Insomnia (sleeplessness): 1 person, 6.25%
Hypersensitivity: 1 person, 6.25%
High Blood Cholesterol: 1 person, 6.25%
Depression: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Triumeq and have Hypertriglyceridaemia?

- Check whether Hypertriglyceridaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triumeq:

Triumeq (6,900 reports)

Hypertriglyceridaemia treatments and more:

Hypertriglyceridaemia (13,032 reports)

How severe was Hypertriglyceridaemia and when was it recovered:

Hypertriglyceridaemia in Triumeq

Expand to all the drugs that have ingredients of abacavir sulfate; dolutegravir sodium; lamivudine:

Hypertriglyceridaemia and drugs with ingredients of abacavir sulfate; dolutegravir sodium; lamivudine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triumeq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (761 drugs)

Browse all the conditions that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (761 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate; dolutegravir sodium; lamivudine (the active ingredients of Triumeq) and Triumeq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.